Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inmune Bio (INMB) Interest & Investment Income (2019 - 2020)

Inmune Bio (INMB) has disclosed Interest & Investment Income for 2 consecutive years, with $21854.0 as the latest value for Q1 2020.

  • Quarterly Interest & Investment Income rose 117.63% to $21854.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $85456.0 through Mar 2020, changed N/A year-over-year, with the annual reading at $77688.0 for FY2019, N/A changed from the prior year.
  • Interest & Investment Income hit $21854.0 in Q1 2020 for Inmune Bio, up from $17220.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $36340.0 in Q2 2019 to a low of $10042.0 in Q1 2019.